非变异性杂质 - - 最近行业在药物开发中使用剂量持续时间限制的经验
Andreanne Lortie1, Elizabeth A Martin2, Kate Arnot3
1Non-Clinical Drug Safety, Ipsen, Les Ulis, France.
Regulatory toxicology and pharmacology : RTP
|December 25, 2023
概括
缺乏关于非变异性杂质合格值的明确指导,导致监管不一致. 为了高效的药物开发和患者获取,需要采用协调的方法,与减少动物试验的原则保持一致.
科学领域:
- 制药发展 制药发展
- 监管科学 监管科学
- 毒理学 毒理学 毒理学
背景情况:
- 临床开发缺乏一致的指导,用于合格的非变异性杂质.
- 这种不一致导致各种各样的赞助商方法和卫生当局的要求.
- 现有的国际协调理事会 (ICH) 准则 (Q3A,Q3B) 提供了一个基准,但经常使用非ICH限制.
研究的目的:
- 调查临床开发中的非变异性杂质合格值的当前做法和监管结果.
- 识别卫生机构要求和赞助商方法中的不一致性.
- 倡导优化资源使用和更快地让患者获得安全药物.
主要方法:
- 2020年3月,在6家欧洲制药工业和协会联合会 (EFPIA) 成员公司中进行了一项调查.
- 在监管提交文件中收集了13个非ICH限制使用案例.
- 对这些例子的监管结果在各种指示和开发阶段进行了分析.
主要成果:
- 早期的临床开发在非变异性杂质限值方面面临的挑战较少.
- 卫生当局通常建议向ICH Q3A和Q3B极限进行进展.
- 观察到不一致的卫生当局请求,甚至在先进瘤患者的早期试验中.
结论:
- 对于有效的药物开发,制定明确,一致的关于非变异性杂质资格的指南至关重要.
- 协调的方法可以加快患者获得安全药物的机会.
- 一致的策略支持资源优化和动物试验的伦理减少 (3Rs).
关键词:
3Rs 考虑因素 考虑因素在EFPIA公司调查中,EFPIA公司调查在ICH M7中使用.在 ICH Q3A/3B 中.在ICH S9上,它是S9.不一致的资格认证方法非ICH限制的例子非变异性杂质 不变异性杂质资源优化 资源的优化监管结果 监管结果更多相关视频
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.7K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
相关概念视频
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Renal Failure: Dose Adjustments
94
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
94
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
